Popular on EntSun
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 289
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 278
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick - 229
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 181
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion - 145
- VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder - 140
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor - 124
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote - 117
- Oliver Sean's "Everyday Will Be Like A Holiday" Featuring the Real Indie Project Hits #1 in Portugal on Christmas Eve - 116
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office - 110
Similar on EntSun
- Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
- The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
- CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
- Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
- American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
- Lineus Medical Completes UK Registration for SafeBreak® Vascular
- 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
- Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
- Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
- Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
Compact Prefilled Syringe Gains Momentum
EntSun News/11081446
Pacto Medical Closes Oversubscribed Seed Round and is Awarded Utility Patent for Novel Compact Prefilled Syringe Technology
EntSun -- Pacto Medical is pleased to announce the successful closing of an oversubscribed seed funding round and the awarding of a US Utility Patent for its innovative compact prefilled syringe technology. These milestones represent significant progress in advancing the commercialization of Pacto Medical's novel prefilled syringe solutions and accelerating the company's mission to improve patient care, health equity, healthcare access and affordability, and sustainability.
Seed Round Completed
The oversubscribed seed round attracted strong interest from investors with backgrounds in healthcare, medtech, pharmaceutical, and social impact sectors. The funding will enable the company to scale its team, form new partnerships with pharmaceutical companies, syringe manufacturers, distributors, and more and accelerate market entry for its compact prefilled syringe platform.
More on EntSun News
Utility Patent Awarded
In parallel, Pacto Medical has been awarded a US Utility Patent (US Patent Number 12,440,623 B2 (https://patents.google.com/patent/US12440623B2/en?peid=642c7b2f5fab0%3A15%3A476672d0)) for its proprietary compact prefilled syringe design. This patent protection strengthens the company's intellectual property portfolio and validates the novelty of its approach to addressing challenges in injectable drug delivery.
"These achievements mark a pivotal moment for Pacto Medical," said Ian Speers, CEO and Co-Founder of Pacto Medical. "The overwhelming investor response to our seed round demonstrates strong confidence in our technology and our utility patent provides a solid foundation for a long-term competitive advantage. We're committed to delivering innovative solutions that make injectable drug delivery safer, simpler, more affordable, more sustainable, and more equitably accessible for patients and healthcare providers around the world."
Pacto Medical is now actively engaging with strategic partners to integrate its compact prefilled syringe technology into various therapeutic areas.
Seed Round Completed
The oversubscribed seed round attracted strong interest from investors with backgrounds in healthcare, medtech, pharmaceutical, and social impact sectors. The funding will enable the company to scale its team, form new partnerships with pharmaceutical companies, syringe manufacturers, distributors, and more and accelerate market entry for its compact prefilled syringe platform.
More on EntSun News
- Epic Pictures Group Sets North American Release Date for the Thriller THE HUNTSMAN
- Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest
- UK Financial Ltd Receives Recognition In Platinum Crypto Academy's "Cryptonaire Weekly"
- P-Wave Press Announces Pushing the Wave 2024 by L.A. Davenport
- Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
Utility Patent Awarded
In parallel, Pacto Medical has been awarded a US Utility Patent (US Patent Number 12,440,623 B2 (https://patents.google.com/patent/US12440623B2/en?peid=642c7b2f5fab0%3A15%3A476672d0)) for its proprietary compact prefilled syringe design. This patent protection strengthens the company's intellectual property portfolio and validates the novelty of its approach to addressing challenges in injectable drug delivery.
"These achievements mark a pivotal moment for Pacto Medical," said Ian Speers, CEO and Co-Founder of Pacto Medical. "The overwhelming investor response to our seed round demonstrates strong confidence in our technology and our utility patent provides a solid foundation for a long-term competitive advantage. We're committed to delivering innovative solutions that make injectable drug delivery safer, simpler, more affordable, more sustainable, and more equitably accessible for patients and healthcare providers around the world."
Pacto Medical is now actively engaging with strategic partners to integrate its compact prefilled syringe technology into various therapeutic areas.
Source: Pacto Medical, Inc.
0 Comments
Latest on EntSun News
- RKP Media Partners With Santani To Elevate Luxury Wellness Brand
- Jones Sign Rebrands as Jones to Reflect Growth, Innovation, and Expanded Capabilities
- Fiery Nova Curates Modern, Everyday Jewelry and Crystals with Style and Subtle Meaning
- $1 Million Share Repurchase Signals Confidence as Off The Hook YS Scales a Tech-Driven Platform in the $57 Billion U.S. Marine Market
- Comedy Returns to Coots Anchorage Friday January 30
- Trends Journal's Top Trends of 2026
- CollabWait to Launch Innovative Waitlist Management Platform for Behavioral Health Services
- Urban Bush Women Celebrates Bessie Award Nominations & Winter 2026 Touring
- Imagen Golf Launches "Precision Lessons" with Trackman iO in Newtown, PA
- New Report Reveals Surprising Trends in Illinois Airport Accidents
- PebblePad Acquires myday to Deliver Unified Digital Campus Experiences for Student Success
- Real comparison: Isee hair's most comprehensive review: Half wig vs. HD lace wig——Which one is more worth buying?
- Adam Clermont Releases New Book – Profit Before People: When Corporations Knew It Was Dangerous and Sold It Anyway
- Banned Iranian Psychological Thriller THE TURTLE Set for UK Theatrical Release
- Love & Laughter : Grammy-nominated R&B Star Stokley Headlines
- Dirty Heads, 311, Tropidelic, and The Movement to Headline Everwild Music Festival in 2026 with its largest lineup to date!
- The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
- Stout Industrial Technology Appoints Paul Bonnett as Chief Executive Officer
- Orlando Hosts Largest Fashion Collaboration as The Fashion Hub Company Opens Its Doors in Downtown Orlando
- Circus Harmony's annual show "Misterioso" celebrates 25th anniversary weekends in February